Peter Dixon

10.6k total citations · 1 hit paper
114 papers, 5.1k citations indexed

About

Peter Dixon is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Peter Dixon has authored 114 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 37 papers in Surgery and 20 papers in Molecular Biology. Recurrent topics in Peter Dixon's work include Drug Transport and Resistance Mechanisms (31 papers), Pediatric Hepatobiliary Diseases and Treatments (30 papers) and Aquaculture disease management and microbiota (10 papers). Peter Dixon is often cited by papers focused on Drug Transport and Resistance Mechanisms (31 papers), Pediatric Hepatobiliary Diseases and Treatments (30 papers) and Aquaculture disease management and microbiota (10 papers). Peter Dixon collaborates with scholars based in United Kingdom, Canada and United States. Peter Dixon's co-authors include Catherine Williamson, Michael Brundage, Nicholas Wood, Joseph L. Pater, Jenny Chambers, Enza Maria Valente, W.J. Mackillop, David G. Payne, Andrew Arnold and Edmund Kostashuk and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Peter Dixon

113 papers receiving 5.0k citations

Hit Papers

Importance of timing for thoracic irradiation in the comb... 1993 2026 2004 2015 1993 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
    1993 515 citations Nevin Murray, Andrew Arnold et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Dixon United Kingdom 40 2.2k 1.3k 1.1k 944 856 114 5.1k
Sture Falkmer Sweden 45 1.7k 0.8× 1.6k 1.2× 1.2k 1.1× 1.5k 1.6× 992 1.2× 244 6.4k
Jennifer Turner Australia 38 1.2k 0.5× 474 0.4× 416 0.4× 960 1.0× 822 1.0× 144 4.8k
Nobuyuki Amino Japan 53 766 0.4× 1.3k 1.0× 893 0.8× 1.7k 1.8× 408 0.5× 363 11.6k
Sadao Kamidono Japan 42 1.4k 0.6× 1.8k 1.4× 482 0.4× 2.2k 2.3× 1.3k 1.6× 385 6.5k
Shigenobu Nagataki Japan 54 1.1k 0.5× 1.7k 1.3× 1.2k 1.1× 2.9k 3.0× 525 0.6× 548 12.1k
Liu H Taiwan 34 1.5k 0.7× 652 0.5× 904 0.8× 1.6k 1.6× 544 0.6× 386 5.4k
Kunihiko Ito Japan 49 834 0.4× 1.5k 1.2× 726 0.7× 1.1k 1.2× 443 0.5× 274 6.7k
Claudio Orlando Italy 42 1.6k 0.7× 460 0.4× 432 0.4× 2.8k 2.9× 676 0.8× 177 6.3k
Masanori Nojima Japan 37 1.2k 0.6× 1.1k 0.9× 711 0.7× 2.3k 2.4× 1.0k 1.2× 322 5.4k
Lee M. Jampol United States 65 539 0.2× 377 0.3× 852 0.8× 1.7k 1.8× 636 0.7× 370 15.0k

Countries citing papers authored by Peter Dixon

Since Specialization
Citations

This map shows the geographic impact of Peter Dixon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Dixon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Dixon more than expected).

Fields of papers citing papers by Peter Dixon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Dixon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Dixon. The network helps show where Peter Dixon may publish in the future.

Co-authorship network of co-authors of Peter Dixon

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Dixon. A scholar is included among the top collaborators of Peter Dixon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Dixon. Peter Dixon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chappell, Lucy C., Jennifer Bell, Anne Smith, et al.. (2020). Ursodeoxycholic Acid Versus Placebo in Women With Intrahepatic Cholestasis of Pregnancy (PITCHES): A Randomized Controlled Trial. Obstetrical & Gynecological Survey. 75(2). 85–86. 1 indexed citations
2.
Ovadia, Caroline, Álvaro Perdones-Montero, Konstantina Spagou, et al.. (2019). Enhanced Microbial Bile Acid Deconjugation and Impaired Ileal Uptake in Pregnancy Repress Intestinal Regulation of Bile Acid Synthesis. Hepatology. 70(1). 276–293. 56 indexed citations
3.
4.
Vasavan, Tharni, et al.. (2018). Heart and bile acids – Clinical consequences of altered bile acid metabolism. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(4). 1345–1355. 91 indexed citations
5.
Dixon, Peter, Richard Paley, Raúl Alegría‐Morán, & Birgit Oidtmann. (2016). Epidemiological characteristics of infectious hematopoietic necrosis virus (IHNV): a review. Veterinary Research. 47(1). 63–63. 139 indexed citations
6.
Geenes, Victoria, Natalie M. Bowman, Peter Dixon, et al.. (2011). A placental phenotype for intrahepatic cholestasis of pregnancy. Placenta. 32(12). 1026–1032. 70 indexed citations
7.
Hill, Barry, Peter Dixon, Birgit Oidtmann, et al.. (2010). Epidemiology of different agents causing disease in aquatic animals. EFSA Supporting Publications. 7(1). 3 indexed citations
8.
Wang, Chiuhui Mary, Peter Dixon, Matt Hodges, et al.. (2009). Identification of 13 novel NLRP7 mutations in 20 families with recurrent hydatidiform mole; missense mutations cluster in the leucine-rich region. Journal of Medical Genetics. 46(8). 569–575. 113 indexed citations
9.
Hoopes, R R, Robert J. Reid, Śaunak Sen, et al.. (2003). Quantitative Trait Loci for Hypercalciuria in a Rat Model of Kidney Stone Disease. Journal of the American Society of Nephrology. 14(7). 1844–1850. 32 indexed citations
10.
Brundage, Michael, Deb Feldman‐Stewart, Roxanne Cosby, et al.. (2001). Cancer patients’ attitudes toward treatment options for advanced non-small cell lung cancer: implications for patient education and decision support. Patient Education and Counseling. 45(2). 149–157. 56 indexed citations
11.
Dixon, Peter, John C. Chambers, J. Weaver, et al.. (2000). Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy. Human Molecular Genetics. 9(8). 5 indexed citations
12.
Dixon, Peter, et al.. (2000). Altered Fractionation of Radical Radiation Therapy in the Management of Unresectable Non-Small Cell Lung Cancer. Current Oncology. 7(2). 98–109. 4 indexed citations
13.
Christie, Paul T., Patrick M. Finnegan, Julie Miller Jones, et al.. (2000). A 5-base pair deletion in the sedlin gene causes spondyloepiphyseal dysplasia tarda in a 6-generation Arkansas kindred.. Journal of Bone and Mineral Research. 15. 2 indexed citations
14.
Mackillop, W.J., S. Zhou, Patti A. Groome, et al.. (1999). Changes in the use of radiotherapy in Ontario 1984–1995. International Journal of Radiation Oncology*Biology*Physics. 44(2). 355–362. 39 indexed citations
15.
Worth, Paul, et al.. (1999). Autosomal Dominant Cerebellar Ataxia Type III: Linkage in a Large British Family to a 7.6-cM Region on Chromosome 15q14-21.3. The American Journal of Human Genetics. 65(2). 420–426. 93 indexed citations
16.
Dixon, Peter, C Wooding, Dorothy Trump, et al.. (1996). Seven novel mutations in the PEX gene indicate molecular heterogeneity for X-linked hypophosphataemic rickets.. Journal of Bone and Mineral Research. 11. 165–165. 1 indexed citations
17.
Mackillop, William J., Henry L. Fu, Carol F. Quirt, et al.. (1995). Re: Dr. Gerner's response to “waiting for radiotherapy in Ontario”. International Journal of Radiation Oncology*Biology*Physics. 32(3). 895–896. 3 indexed citations
18.
Coy, Peter, D. Ian Hodson, Nevin Murray, et al.. (1994). Patterns of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer. International Journal of Radiation Oncology*Biology*Physics. 28(2). 355–362. 17 indexed citations
19.
20.
Goodman, George, Julie Bowen, Peter Dixon, et al.. (1990). PIMESON RADIOTHERAPY AT TRIUMF. 2(2). 85–99. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sture Falkmer Breakdown of academic impact, for papers by Jennifer Turner Breakdown of academic impact, for papers by Nobuyuki Amino Breakdown of academic impact, for papers by Sadao Kamidono Breakdown of academic impact, for papers by Shigenobu Nagataki Breakdown of academic impact, for papers by Liu H Breakdown of academic impact, for papers by Kunihiko Ito Breakdown of academic impact, for papers by Claudio Orlando Breakdown of academic impact, for papers by Masanori Nojima Breakdown of academic impact, for papers by Lee M. Jampol
Rankless by CCL
2026